Agilent Life Sciences SS Tumor Map Assay Probe, DNA, 16, EA
The Agilent SureSelect XT HS2 DNA Tumor Map Assay Probe Kit (part number 5191-7430) is designed for high-sensitivity, targeted DNA sequencing applications in oncology research. This kit enables comprehensive tumor profiling by providing probes for hybrid capture-based enrichment of genomic regions relevant to cancer. It supports up to 16 reactions and is optimized for use with low-input and degraded DNA samples, such as those derived from formalin-fixed, paraffin-embedded (FFPE) tissues. The kit is compatible with Illumina sequencing platforms and integrates with Agilent's SureSelect workflows for streamlined library preparation, target enrichment, and sequencing, facilitating accurate detection of somatic variants in tumor samples.